80% of moneycontrol users recommend buying Vivimed Labs.
What's your call on Vivimed Labs today?
Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2927.00||1.26||2941.10||2198.35||49,857.07|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Thomas Cook (India) Recommended on May 9th 2014
Recommended price 89.00 | Peak from reco 150.00 68.16%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Vivimed Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 489.44 crore.The company has reported a consolidated sales of Rs 368.17 crore and a Net Profit of Rs 11.04 crore for the quarter ended Mar 2014.
The company management includes Santosh Varalwar - Managing Director & CEO, V Manohar Rao - Whole Time Director, Subhash Varalwar - Whole Time Director, Sandeep Varalwar - Whole Time Director, S Raghunandan - Whole Time Director, P V Rathnam - Independent Director, M Bhagvanth Rao - Independent Director, Peesapati Venkateswarlu - Independent Director, Nixon Patel - Independent Director, Srinivas Chidambaram - Nominee Director.
It is listed on the BSE with a BSE Code of 532660 and the NSE with an NSE Code of VIVIMEDLAB.
Its Registered office is at Speciality Chemicals Division: Plot No.78-A,,Kolhar Industrial Area Bidar,Karnataka - 585403.
Their Registrars are Aarthi Consultants Pvt Ltd